KALLISIO INC.

Kallisio is a medtech innovator transforming the delivery of precision cancer therapy through personalized intraoral devices. We design and manufacture patient-specific, 3D-printed oral stents that enhance treatment accuracy, protect healthy tissue, and improve patient outcomes in head and neck radiation therapy. Our 1st product, Stentra™, is currently being piloted at leading U.S. cancer centers.